Ensurge (ESGI) 10-K 12 Dec 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 09, 2014	Jun. 30, 2013
Document and Entity Information	'	'	'
Entity Registrant Name	'ENSURGE INC	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Entity Central Index Key	'0000789879	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Common Stock, Shares Outstanding	'	77,358,726	'
Entity Public Float	'	'	$5,549,285
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets	'	'
Cash	$351	$15,252
Total Current Assets	351	15,252
Fixed assets (net of depreciation)	'	49,451
Investment in TransGlobal, net of reserves of $322,400	'	'
Total Other Assets	'	49,451
Total Assets	351	64,703
Current Liabilities	'	'
Trade accounts payable	177,490	171,750
Accrued liabilities	330,075	171,875
Accrued interest payable	22,005	14,771
Convertible note payable net of debt discount of $38,678	3,822	'
Notes payable	209,050	1,662,500
Proceeds for common stock to be issued	1,360,000	1,360,000
Debt derivative liability	60,324	'
Warrants derivative liability	314,305	903,142
Total Current Liabilities	2,477,071	4,284,038
Stockholders' Deficit	'	'
Common stock - $0.001 par value; 100,000,000 shares authorized; 67,228,726 and 34,038,726 shares issued and outstanding, respectively	67,229	34,038
Additional paid-in-capital	56,609,618	55,209,889
Stock subscription receivable	-75,000	'
Accumulated deficit	-23,315,973	-23,315,973
Exploration stage deficit	-35,762,594	-36,147,289
Total Stockholders' Deficit	-2,476,720	-4,219,335
Total Liabilities and Stockholders' Deficit	$351	$64,703

BALANCE_SHEETS_PARENTHETICAL

BALANCE SHEETS (PARENTHETICAL) (USD $)	Dec. 31, 2013	Dec. 31, 2012
BALANCE SHEETS (PARENTHETICAL)	'	'
Reserves on Investment	$322,400	'
Convertible Note Payable Debt Discount	$38,678	'
Common Stock par value	$0.00	$0.00
Common stock shares authorized	100,000,000	100,000,000
Common stock shares issued	67,228,726	67,228,726
Common stock shares outstanding	34,038,726	34,038,726

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	12 Months Ended		48 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
STATEMENTS OF OPERATIONS	'	'	'
Sales	'	'	'
General and administrative	907,152	9,501,196	30,556,787
Total Operating Expenses	907,152	9,501,196	30,556,787
Operating Loss	-907,152	-9,501,196	-30,556,787
Derivative gain	602,173	10,433,970	7,761,710
Gain on sale of subsidiary	1,676,354	'	1,676,354
Loss on sale of fixed assets, net	-39,610	'	-39,610
Impairment of goodwill	-660,000	'	-660,000
Derivative day-one loss	-31,160	'	-12,001,639
Interest Expense	-255,910	-498,937	-1,946,180
Interest income	'	230	3,558
Total Other income (expense)	1,295,669	9,935,263	-5,205,807
Net Income (Loss)	$384,695	$434,067	($35,762,594)
Basic Earnings (Loss) Per Common Share	$0.01	$0.01	'
Basic Weighted Average Common Shares Outstanding	54,019,051	33,006,622	'
Diluted Earnings (Loss) Per Common Share	$0.01	$0.01	'
Diluted Weighted Average Common Shares Outstanding	60,962,233	41,358,316	'

STATEMENTS_OF_CHANGES_IN_STOCK

STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (USD $)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2010	$29,485	$26,088,412	($38,402,985)	($12,285,088)
Balance - Shares at Dec. 31, 2010	29,485,341	'	'	'
Stock issued as exercise of warrants	2,986	5,396,791	'	5,399,777
Stock issued as exercise of warrants - shares	2,986,385	'	'	'
Stock issued for services	252	745,548	'	745,800
Stock issued for services - Shares	252,000	'	'	'
Option expense	'	14,263,604	'	14,263,604
Stock cancelled	-375	375	'	'
Stock cancelled - shares	-375,000	'	'	'
Net Income (Loss)	'	'	-21,494,344	-21,494,344
Balance at Dec. 31, 2011	32,348	46,494,730	-59,897,329	-13,370,251
Balance - Shares at Dec. 31, 2011	32,348,726	'	'	'
Stock sold for cash	760	170,284	'	171,044
Stock sold for cash - Shares	760,000	'	'	'
Stock issued for services	30	14,970	'	15,000
Stock issued for services - Shares	30,000	'	'	'
Stock issued for interest expense	900	89,100	'	90,000
Stock issued for interest expense - Shares	900,000	'	'	'
Option expense	'	8,440,805	'	8,440,805
Net Income (Loss)	'	'	434,067	434,067
Balance at Dec. 31, 2012	34,038	55,209,889	-59,463,262	-4,219,335
Balance - Shares at Dec. 31, 2012	34,038,726	'	'	'
Stock issued for services	2,220	118,580	'	120,800
Stock issued for services - Shares	2,220,000	'	'	'
Stock issued for interest expense	3,000	78,000	'	81,000
Stock issued for interest expense - Shares	3,000,000	'	'	'
Stock issued for accrued expenses	2,000	8,000	'	10,000
Stock issued for accrued expenses - Shares	2,000,000	'	'	'
Stock issued for acquisition of TransGlobal	6,000	654,000	'	660,000
Stock issued for acquisition of TransGlobal - Shares	6,000,000	'	'	'
Stock issued for investment in TransGlobal	4,970	297,830	'	302,800
Stock issued for investment in TransGlobal - Shares	4,970,000	'	'	'
Accrued wages forgiven	'	108,750	'	108,750
Fair value of warrants issued for services	'	74,569	'	74,569
Net Income (Loss)	'	'	384,695	384,695
Balance at Dec. 31, 2013	67,228	56,609,618	-59,078,567	-2,476,720
Stock subscription receivable - Shares at Dec. 31, 2013	15,000,000	'	'	'
Stock subscription receivable at Dec. 31, 2013	15,000	60,000	'	-75,000
Balance - Shares at Dec. 31, 2013	67,228,726	'	'	'
Balance at Dec. 31, 2009	26,035	23,266,514	-23,315,973	-23,424
Balance - Shares at Dec. 31, 2009	26,035,341	'	'	'
Stock sold for cash	3,100	891,800	'	894,900
Stock sold for cash - Shares	3,100,000	'	'	'
Stock issued for services	2,350	1,049,150	'	1,051,500
Stock issued for services - Shares	2,350,000	'	'	'
Purchase and cancel treasury stock	-2,000	-58,000	'	-60,000
Purchase and cancel treasury stock - Shares	-2,000,000	'	'	'
Option expense	'	1,152,469	'	1,152,469
Warrants	'	-213,521	'	-213,521
Net Income (Loss)	'	'	-15,087,012	-15,087,012
Balance at Dec. 31, 2010	$29,485	$26,088,412	($38,402,985)	($12,285,088)
Balance - Shares at Dec. 31, 2010	29,485,341	'	'	'

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		48 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Cash Flows From Operating Activities	'	'	'
Net Income (Loss)	$384,695	$434,067	($35,762,594)
Adjustments to reconcile net income (loss) to net cash used in operating activities:	'	'	'
Common stock and options issued for services	120,800	8,455,805	26,859,479
Derivative gain	-602,173	-10,433,971	-7,761,711
Amortization of debt discount	3,822	110,000	113,822
Stock issued for interest	81,000	90,000	171,000
Non-cash interest expense	'	302,500	302,500
Derivative day-one loss	31,160	'	12,001,639
Depreciation expense	8,291	8,485	17,730
Impairment of goodwill	660,000	'	660,000
Loss on sale of fixed assets, net	39,610	'	39,610
Bad debt	322,400	'	322,400
Fair value of warrants issued for services	74,569	'	74,569
Operating expenses incurred by note holder	17,350	'	17,350
Gain on sale of subsidiary	-1,676,354	'	-1,676,354
Changes in operating assets and liabilities:	'	'	'
Increase in trade accounts payable	5,740	135,536	168,804
Increase (decrease) in accrued expenses	276,951	-3,562	276,985
Increase in accrued liabilities	171,088	171,875	342,963
Net Cash Used in Operating Activities	-81,051	-729,265	-3,831,809
Cash Flows From Investing Activities	'	'	'
Proceeds from sale of fixed assets	1,550	'	1,550
Investment in fixed assets	'	'	-58,890
Investment in TransGlobal	-19,600	'	-19,600
Net Cash Used by Investing Activities	-18,050	'	-76,940
Cash Flows From Financing Activities	'	'	'
Proceeds from notes payable	84,200	150,000	1,834,200
Repayments of notes payable	'	'	-500,000
Proceeds from exercise of warrants for common stock to be issued	'	'	1,360,000
Purchase treasury stock	'	'	-60,000
Proceeds from issuance of common stock	'	380,000	1,274,900
Net Cash Provided by Financing Activities	84,200	530,000	3,909,100
Net (decrease) increase in Cash	-14,901	-199,265	351
Cash at Beginning of Period	15,252	214,517	'
Cash at End of Period	351	15,252	351
Cash paid during the period for:	'	'	'
Interest	'	'	'
Income taxes	'	'	'
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'
Stock issued for accrued expenses	10,000	'	10,000
Accrued wages forgiven	108,750	'	108,750
Stock subscription receivable	75,000	'	75,000
Derivative liability at inception	73,660	'	73,660
Stock issued for investment in TransGlobal	$302,800	'	$302,800

Note_1_Summary_of_Significant_

Note 1 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 1 - Summary of Significant Accounting Policies	'
	NOTE 1–SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Organization and Liquidation – On October 16, 2000, iShopper.com, Inc. changed its name to Ensurge, Inc. Ensurge, Inc. is referred to herein as the Company.  On January 1, 2002, the Company began liquidation of its assets.  During 2009 the Company started a new phase of operations with the mining industry; accordingly, the accompanying financial statements are presented on a GAAP basis of accounting, rather than on a liquidation basis.
	Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.
	Basis of Presentation – Going Concern
	The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern. The Company is under exploration stage and has not commenced its planned operations. As shown in the accompanying consolidated financial statements, the Company has not generated any revenue and has incurred recurring losses for the period from January 1, 2010 (date of inception of exploration stage) through December 31, 2013. Additionally, the Company has negative cash flows from operating activities, has stockholders’ deficit and working capital deficit. Therefore it may be forced to discontinue operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	Management plans to raise additional capital to complete its business plan. However, there can be no assurance that these arrangements will be sufficient to fund its ongoing capital expenditures, working capital, and other cash requirements. The outcome of these matters cannot be predicted at this time.
	There can be no assurance that any additional financings will be available to the Company on satisfactory terms and conditions, if at all.
	The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.
	Business Condition – The Company has suffered losses from operations, has had negative cash flows from operating activities for all periods since inception. The Company has issued a private placement memorandum to obtain investors. During 2010, the Company sold an aggregate of 3,100,000 shares of common stock to investors for an aggregate purchase price of $894,900 in a private placement. The Company received $1,360,000 in exchange for warrants exercisable for the right to purchase 5,600,000 shares of the Company’s common stock in a private placement. In August 2011 the Company entered into a 90 day note payable in the amount of $500,000. During October 2011 the Company entered into a two 12 month notes payable for an aggregate of $1,100,000, which proceeds were used to pay off early the 90 day note and operating capital. During November 2012, the Company negotiated an extension of these two notes payable, which are due on March 15, 2013. The principal was increase from $550,000 per note to $756,250, or a total of $1,512,500. As part of this negotiation to extend the note, the Company agreed to pay a total of 900,000 shares of common stock.
	On March 2, 2012, the Company accepted $380,000 in private placement funds from accredited investors in exchange for units consisting of seven hundred sixty thousand (760,000) shares of the Company’s common stock, plus three hundred eighty thousand (380,000) warrants with an exercise price of $1.00.  During November 2012 the Company entered into several 12 month notes payable for an aggregate of $150,000. The proceeds of the financing will be used to help the Company maintain operations and to fund the exploration of acquisitions.
	Principles of Consolidation – The financial statements have been consolidated with its wholly owned subsidiary, Ensurge Brazil, LTDA., which was incorporated in Sao Paulo, Brazil on April 18, 2011.  Currently the Brazil entity has no assets, liabilities, revenues or expenses.  During December 2013, the Company divested itself of the Brazil entity, including all assets and liabilities.
	Stock-Based Compensation – Effective January 1, 2006, the Company adopted, “Share-Based Payment” (ASC Topic 718) requiring that compensation cost relating to share-based payment awards made to employees and directors be recognized in the consolidated financial statements. There were no options granted during the years ended December 31, 2013 and 2012.
	Prior to January 1, 2006, the Company accounted for its stock options issued to directors, officers and employees under ASC Topic 835 and related interpretations. Under ASC Topic 835, compensation expense is recognized if an option’s exercise price on the measurement date is below the fair value of the Company’s common stock. The Company also accounted for options and warrants issued to non-
	employees in accordance with ASC Topic 718 which required these options and warrants to be accounted for at their fair value.
	Basic and Diluted Earnings Per Share – Basic loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is calculated to give effect to potentially issuable common shares which include stock options and stock warrants except during loss periods when those potentially issuable common shares would decrease loss per share. During 2013, the Company issued 33,190,000 common shares and 2,822,000 warrants as part of debt financing and services.  During 2012, the Company issued 1,690,000 common shares and 380,000 warrants as part of private placement funding, debt financing and services.
	Income Taxes – The Company recognizes an asset or liability for the deferred tax consequences of all temporary differences between the tax bases of assets or liabilities and their reported amounts in the financial statements that will result in taxable or deductible amounts in future years when the reported amounts of the asset or liabilities are recovered or settled and for operating loss carry forwards. These deferred tax assets and liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to reverse and the carry forwards are expected to be realized. Deferred tax assets are reviewed periodically for recoverability and a valuation allowance is provided as necessary.
	Cash and Cash Equivalents - The Company considers all highly liquid instruments purchased with an original maturity of three months or less and money market accounts to be cash equivalents. There were no cash equivalents at December 31, 2013 and 2012.
	Derivative Liabilities - The Company assessed the classification of its derivative financial instruments as of December 31, 2013, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.
	ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.
	Fair Value of Financial Instruments - Effective January 1, 2008, the Company adopted FASB ASC 820-Fair Value Measurements and Disclosures, or ASC 820, for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures.
	ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:
	Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities
	Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data
	Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions
	The Company did not have any Level 2 or Level 3 assets or liabilities as of December 31, 2013, with the exception of its convertible notes payable. The carrying amounts of these liabilities at December 31, 2013 approximate their respective fair value based on the Company’s incremental borrowing rate.
	Cash is considered to be highly liquid and easily tradable as of December 31, 2013 and therefore classified as Level 1 within our fair value hierarchy.
	In addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments.
	Convertible Instruments - The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.
	Professional standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of “Conventional Convertible Debt Instrument”.
	The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.
	ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.
	Property and Equipment - Property and equipment are stated at cost. Depreciation is computed on the straight-line method. The depreciation and amortization methods are designed to amortize the cost of the assets over their estimated useful lives.
	Amortization of leasehold improvements is computed using the straight-line method over the shorter of the life of the lease or the estimated useful life of the assets. Maintenance and repairs are charged to expense as incurred. Improvements of a major nature are capitalized. At the time of retirement or other disposition of property and equipment, the cost and accumulated depreciation are removed from the accounts and any gains or losses are reflected in income.
	The Company reviews the carrying value of property and equipment for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of assets. The factors considered by management in performing this assessment include current operating results, trends and prospects, the manner in which the property is used, and the effects of obsolescence, demand, competition, and other economic factors. Based on this assessment there was no impairment at December 31, 2013 and 2012.
	Recently Enacted Accounting Standards – The Company will adopt in future the Accounting Standards Update (ASU) No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this ASU remove all incremental financial reporting requirements from U.S. GAAP for development stage entities, including the removal of Topic 915, Development Stage Entities, from the FASB Accounting Standards Codification.
	A development stage entity is one that devotes substantially all of its efforts to establishing a new business and for which: (a) planned principal operations have not commenced; or (b) planned principal operations have commenced, but have produced no significant revenue. For example, many start-ups or even long-lived organizations that have not yet begun their principal operations or do not have significant revenue would be identified as development stage entities.
	For public business entities, the presentation and disclosure requirements in Topic 915 will no longer be required for the first annual period beginning after December 15, 2014. The revised consolidation standards are effective one year later, in annual periods beginning after December 15, 2015. Early adoption is permitted.
	We have reviewed accounting pronouncements issued during the past two years and have adopted any that are applicable to our company. We have determined that none had a material impact on our consolidated financial position, results of operations, or cash flows for the years ended December 31, 2013 and 2012.

Note_2_Investment_in_Mining_Ri

Note 2 - Investment in Mining Rights	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 2 - Investment in Mining Rights	'
	NOTE 2 – INVESTMENT IN MINING RIGHTS
	It is the Company’s policy to capitalize engineering costs associated with a project that is put under contract and amortize it over the life of the project.  The Company will complete an impairment analysis at the end of each year.  During 2013 and 2012, the Company had mining development and engineering expenses related to research of new projects of $0 and $106,592, respectively.

Note_3_Proceeds_For_Common_Sto

Note 3 - Proceeds For Common Stock To Be Issued	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 3 - Proceeds For Common Stock To Be Issued	'
	NOTE 3 – PROCEEDS FOR COMMON STOCK TO BE ISSUED
	During 2012, the Company issued 30,000 shares of common stock in exchange for services valued at $15,000.  The valuation was based on the market price at the date of services.
	During November 2012, the Company negotiated an extension of two notes payable.  As part of this negotiation to extend the note, the Company agreed to pay a total of 900,000 shares of common stock.
	March 2, 2012, the Company accepted $380,000 in private placement funds from accredited investors in exchange for units consisting of seven hundred sixty thousand (760,000) shares of the Company’s common stock, plus three hundred eighty thousand (380,000) warrants with an exercise price of $1.00.
	During 2011, the Company issued 252,000 shares of common stock in exchange for services valued at $745,800. The valuation was based on the market price at the date of services. The Company cancelled 375,000 shares of common stock, which had been issued as part of a consulting agreement. The conditions of the agreement were never fulfilled, so the agreement and the shares associated were cancelled. In August 2011 the Company entered into a 90 day note payable with interest and warrants payable. After the note was fully paid, the note holder decided to exercise the warrants, using the cashless exercise option of the agreement. As part of the cashless exercise the note holder received 2,945,250 shares of common stock.
	During July 2010, the Company sold 4,000,000 warrants for $100 for the right to purchase 4,000,000 shares of common stock at $0.14 per share or $560,000. $560,100 was received in July for the warrants and the exercise of the warrants. In December 2010, the Company received $800,000 in exchange for warrants exercisable for the right to purchase 1,600,000 shares of the Company’s common stock in a private placement. The cash has been received, however the warrants have not been exercised thus the common stock has not been issued to the purchaser. The nature of this warrant requires the Company to record a Warrant Derivative Liability. The valuation of the derivative is determined using the lattice model.

Note_4_Plant_Property_and_Equi

Note 4 - Plant, Property and Equipment	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 4 - Plant, Property and Equipment	'
	NOTE 4 - PLANT, PROPERTY AND EQUIPMENT
	The following table summarizes Company’s plant, property and equipment as of December 31, 2013 and 2012.
		2013	2012
	Equipment	$            -	$     55,073
	Computer hardware	-	3,817
	Accumulated depreciation		-9,439
		-
		$           -	$    49,451
	In June 2013 the Company sold Computer server for $1,550 having a net book value of $1,167, hence recorded a gain on sale of fixed assets of $383.
	During the year ended December 31, 2013 the Company written off Mining Equipment in Guyana having a net book value of $39,993, hence recorded a loss on write off of fixed assets of $39,993.
	Depreciation expenses for the year ended December 31, 2013 and 2012 was $8,291 and $8,485 respectively.

Note_5_Warrant_Derivative_Liab

Note 5 - Warrant Derivative Liability	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 5 - Warrant Derivative Liability	'
	NOTE 5 – WARRANT DERIVATIVE LIABILITY
	As part of the warrants issued for common stock in previous years, the nature of the warrants requires the Company to record a Warrant Derivative Liability in the amount of $314,305 and $903,142 at December 31, 2013 and 2012, respectively.  The valuation of the derivative is determined using the lattice model.  The lattice model is based in part on the price the stock is trading on the day the warrants are issued and again at the end of each quarter and year end.  Due to the stock price having large swings, the warrant derivative liability has large swings also, which create large losses and gains.

Note_6_Common_Stock_Warrants_a

Note 6 - Common Stock Warrants and Options	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 6 - Common Stock Warrants and Options	'
	NOTE 6 – COMMON STOCK WARRANTS AND OPTIONS
	As of December 31, 2013 the Company had common stock warrants outstanding of 11,152,000 and outstanding options of 7,500,000.  Warrants have a term of 2 to 5 years and options have a term of 10 years.
		Options				Warrants
		12/31/13		12/31/12		12/31/13		12/31/12
	Beginning Balance	7,500,000		7,500,000		8,330,000		7,950,000
	Granted/Issued	-		-		2,822,000		380,000
	Exercised	-		-		-		-
	Cancelled	-		-		-		-
	End Balance	7,500,000		7,500,000		11,152,000		8,330,000
	Exercisable	7,500,000		7,500,000		11,152,000		8,330,000
	Warrants – We have granted outstanding warrants for the purchase of a total of 11,152,000 shares of our common stock, all of which are exercisable anytime until their respective expiration dates
	Date of issuance	Stock price at valuation date of May 30, 2013 and	Exercise price	Term	Risk free rate	Volatility	Value	# of Warrants
		December 31, 2013
	30-May-13	$           0.04	$   0.75	2 Year	0.36%	316%	$               -	420,000
	30-May-13	$           0.04	$   0.50	2 Year	0.36%	316%	$               -	420,000
	30-May-13	$           0.04	$   0.38	2 Year	0.36%	316%	$               -	420,000
	30-May-13	$           0.04	$   0.25	2 Year	0.36%	316%	$               -	142,000
	30-May-13	$           0.04	$   0.13	2 Year	0.36%	316%	$               -	1,420,000
	2-Mar-12	$           0.04	$   1.00	5 Year	0.36%	316%	$               -	380,000
	28-Oct-11	$           0.04	$  1.00	5 Year	0.36%	316%	$               -	1,900,000
	30-Dec-10	$           0.04	$   0.50	5 Year	0.36%	316%	$               -	1,600,000
	9-Dec-10	$           0.04	$   1.00	5 Year	0.36%	316%	$               -	450,000
	27-Jul-10	$           0.04	$   0.14	5 Year	0.36%	316%	$               -	4,000,000
	Total						$               -	11,152,000
	The following is a summary of the Company’s stock warrants outstanding as of December 31, 2013, adjusted for any changes in the exercise price of the stock warrants:
		Warrants Outstanding					Warrants Exercisable
		Range of exercise price	Number Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable	Weighted Average Exercise Price
		$0.13	11,152,000	2.96 years	$          0.50		11,152,000	$    0.50
		to $1.00
			Exercise Price		$0.13
					to $1.00
			Term		Two to
					Five years25
			Volatility		261%
			Dividends		0%
	The following is a summary of the Company’s stock options outstanding as of December 31, 2013, adjusted for any changes in the exercise price of the stock options:
		Options Outstanding					Options Exercisable
		Range of exercise price	Number Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable	Weighted Average Exercise Price
		$0.14 to $0.50	7,500,000	7.63 years	$            0.25		7,500,000	$        0.25

Note_7_Issuance_of_Stock

Note 7 - Issuance of Stock	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 7 - Issuance of Stock	'
	NOTE 7 – ISSUANCE OF STOCK
	During 2012, the Company issued 30,000 shares of common stock in exchange for services valued at $15,000.  The valuation was based on the market price at the date of services.
	During November 2012, the Company negotiated an extension of two notes payable.  As part of this negotiation to extend the note, the Company agreed to pay a total of 900,000 shares of common stock.
	March 2, 2012, the Company accepted $380,000 in private placement funds from accredited investors in exchange for units consisting of seven hundred sixty thousand (760,000) shares of the Company’s common stock, plus three hundred eighty thousand (380,000) warrants with an exercise price of $1.00.
	On May 15, 2013, the Company entered into an agreement with Next View Capital, LP and Zadar, LLC, which have notes payable with an aggregate total of $1,512,500.  As part of this agreement, these two notes will be moved to the Company’s wholly owned subsidiary, Ensurge Brasil, LTDA, thereby releasing Ensurge, Inc. of this Liability.  As part of this agreement the Company issued 1,000,000 shares of common stock to each note holder valued at $38,000 each.
	On May 23, 2013, the Company issued 6,000,000 shares of common stock for 80% ownership of TransGlobal Gold Corp, a Nevada Corporation and 200,000 shares to employees valued at $660,000 and $22,000 respectively.
	On May 22, 2013, the Company issued 2,000,000 shares of common stock to its CEO in exchange for past due wages of $10,000.
	On May 22, 2013, the Company issued 1,000,000 shares of common stock as part of its negotiation with an entity to provide cash and a note payable valued at $5,000.
	On May 22, 2013, the Company entered into a 24 month 5% note receivable for $50,000 in exchange for 10,000,000 shares of common stock with Workhorse Capital Leasing LLC.  As of December 31, 2013, this is disclosed as stock subscription receivable.
	On May 22, 2013, the Company entered into a 24 month 5% note receivable for $25,000 in exchange for 5,000,000 shares of common stock with OG3 LLC.  As of December 31, 2013, this is disclosed as stock subscription receivable.
	On May 30, 2013, the Company entered into an employment agreement with its new President and as part of the negotiation, the Company issued 1,420,000 shares of common stock valued at $56,800 and 2,822,000 warrants ranging from a price of $0.125 to $0.75.  These warrants have a 2 year term and vest 10% each month starting on the date of the employment agreement.
	On July 10, 2013, the Company issued 500,000 shares of common stock valued at $30,000 to the Vice President of TransGlobal Gold Corp, which Ensurge owns 80%, for current and future services.  The entire incentive package is 2,000,000 shares of common stock which 500,000 shares vest every six months.
	On August 1, 2013, the Company issued 3,500,000 shares of common stock valued at $210,000 to various employees and persons that have paid for expenses and equipment for TransGlobal Gold Corp which is shown as investment and during the year ended December 31, 2013, 100% reserve for doubtful has been provided.
	On August 16, 2013, the Company issued 400,000 shares of common stock valued at $40,000 in exchange for equipment purchased for TransGlobal Gold Corp which is shown as investment and during the year ended December 31, 2013, 100% reserve for doubtful has been provided.
	On September 5, 2013, the Company issued 600,000 shares of common stock valued at $42,000 for services for Ensurge.
	On October 21, 2013, the Company issued 570,000 shares of common stock valued at $22,800 for services performed for TransGlobal Gold Corp which is shown as investment and during the year ended December 31, 2013, 100% reserve for doubtful has been provided.
	Proceeds from common stocks to be issued:
	In February 2010 and March 2010, the Company sold an aggregate of 2,100,000 shares of common stock to investors for an aggregate purchase price of $525,000 in a private placement. In July 2010, the Company received $560,000 in exchange for warrants exercisable for the right to purchase 4,000,000 shares of the Company’s common stock in a private placement. In December 2010, the Company sold an aggregate of 1,000,000 shares of common stock and 500,000 warrants exercisable for $1 to investors for an aggregate purchase price of $500,000 in a private placement. In December 2010, the Company received $800,000 in exchange for warrants exercisable for the right to purchase 1,600,000 shares of the Company’s common stock in a private placement. These transactions were exempt from registration pursuant to Section 4(2) of the Securities Act.

Note_8_Notes_Payable

Note 8 - Notes Payable	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 8 - Notes Payable	'
	NOTE 8 – NOTES PAYABLE
	In August 2011 the Company entered into two 90 day convertible Notes Payable for $280,500 each, from Bristol Investment Funds and St. George Investments. These notes also include 280,500 warrants each for a total of 561,000 warrants at an exercise price of $1.00 per share. Using the Lattice model, we valued these warrants based on the closing price of the market at $3.00 for additional interest expense of $1,122,000, which equates to an effective interest rate of 3,310%. During December 2011, these warrants were exercised using the cashless exercise provision within the agreement and a total of 2,945,250 shares of common stock.
	During the month of October 2011 the Company entered into two twelve month convertible Notes Payable for $605,000 each, for a total funding of $1,210,000, with an initial issue discount of 10% and total proceeds of $1,100,000, which are collateralized by all the assets of the Company. These notes may be converted at a fixed price of $1.50 per share of the Company’s common stock. However, if the Company obtained other financing at a lower price, then the shares issued would be adjusted to reflect the price difference. These notes also include 950,000 warrants each for a total of 1,900,000 warrants at an exercise price of $1.00 per share and have a cashless exercise provision. In case of default the Note may be converted into common stock at $1.50 per share or 80% of the current market bid price, whichever is lower. A total of $561,000 of these funds were used to pay back the 90 day convertible Notes Payable, which were paid in full on October 31, 2011.
	During November 2012, the Company negotiated an extension of the two October 2011 notes payable.  The principal was increased from $550,000 per note to $756,250, or a total of $1,512,500 with an annual interest rate of 10%.  On December 31, 2013, this note was moved to Ensurge Brasil LTDA, subsidiary of the company (refer note 15).
	During November 2012 the Company entered into several 12 month notes payable for an aggregate of $150,000, with an annual interest rate of 10%.
	During April 2013, the Company entered into a 60 day 10% convertible note payable for $15,000, which has not been paid off nor converted into stock.  Due to the note being in default the interest rate has now increased to 18%.
	On May 9, 2013, the Company entered into a 6 month note payable of $23,000 with interest payable at 22% APR.  As part of this note the Company issued 1,000,000 shares of common stock valued at $5,000.
	On August 16, 2013, the Company entered into a 12 month note payable of $9,000 with interest payable at 5% APR.
	On August 30, 2013, the Company entered into a 12 month note payable of $5,000 with interest payable at 5% APR.
	During October 2013 and November 2013, the Company entered into three notes payable for a total of $7,050, with interest payable at 5%.

Note_9_Convertible_Notes_Payab

Note 9 - Convertible Notes Payable	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 9 - Convertible Notes Payable	'
	NOTE 9 – CONVERTIBLE NOTES PAYABLE
	On December 6, 2013, the Company entered into a nine months convertible note payable of $42,500 with interest payable at 8% APR.  The note is convertible into the Company’s common stock at the holder’s option, at the conversion rate 58% of average of the lowest three trading prices during ten trading days period prior to the date of conversion.
	The Company identified embedded derivatives related to the Convertible Promissory Note entered into on December 13, 2013. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $73,660 of the embedded derivative. The fair value of the embedded derivative was determined using the Binomial Lattice Model based on the following assumptions:
	Dividend yield:	-0-	%
	Volatility	312.15	%
	Risk free rate:	0.38	%
	On December 6, 2013 the initial fair value of the embedded debt derivative of $73,660 was allocated as a debt discount up to the proceeds of the note ($42,500) with the remainder ($31,160) charged to current period operations as interest expense.
	The fair value of the described embedded derivative of $60,324 at December 31, 2013 was determined using the Binomial Lattice Model with the following assumptions:
	Dividend yield:	-0-	%
	Volatility	483	%
	Risk free rate:	0.13	%
	At December 31, 2013, the Company adjusted the recorded fair value of the derivative liability to market on notes resulting in noncash, non-operating gain of $13,336 for the year ended December 31, 2013.
	The debt discount attributed to the beneficial conversion feature is amortized and charged to current period operations as interest expense over the term of the note. During the year ended December 31, 2013 and 2012, the Company amortized $3,822 and $-0-, respectively, of beneficial debt discount to the operations as interest expense.

Note_10_Fair_Value_of_Financia

Note 10 - Fair Value of Financial Instrument	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 10 - Fair Value of Financial Instrument	'
	NOTE 10 – FAIR VALUE OF FINANCIAL INSTRUMENT
	ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:
	Level 1 - Quoted prices in active markets for identical assets or liabilities.
	Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.
	To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the lowest level input that is significant to the fair value measurement.
	Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2013:
					Fair Value Measurements at December 31, 2013 using:
		December 31,			Quoted Prices			Significant		Significant
		2013			in Active			Other		Unobservable
					Markets for			Observable		Inputs
					Identical			Inputs (Level 2)		(Level 3)
					Assets
					(Level 1)
	Liabilities:
	Debt Derivative Liabilities	$	60,324			-			-	$	60,324
	Warrant Derivative Liabilities	$	314,305				-		-	$	314,305
	The debt derivative  and warrant liabilities are measured at fair value using quoted market prices and estimated volatility factors based on historical prices for the Company’s common stock and are classified within Level 3 of the valuation hierarchy.
	The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of December 31, 2013 and 2012:
		Debt Derivative			Warrant Derivative Liability
		Liability
	Balance, December 31, 2012	$	-	$	903,142
	Initial fair value of debt derivatives at note issuances on December 6, 2013		73,660		-
	Change in fair value of derivative liability		-13,336		-588,837
	Balance, December 31, 2013	$	60,324	$	314,305
	Net gain for the period included in earnings relating to the liabilities held at December 31, 2013	$	13,336		588,837
				$
	Level 3 Liabilities are comprised of our bifurcated convertible debt and warrant liabilities features on Companies convertible notes and warrants.

Note_11_Provision_For_Income_T

Note 11 - Provision For Income Taxes	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 11 - Provision For Income Taxes	'
	NOTE 11 – PROVISION FOR INCOME TAXES
	The Company has net operating loss carry forwards of approximately $15,605,084 at December 31, 2013. The net operating loss carry forwards expire from 2022 through 2033. Substantially all of the operating loss carry forwards are limited in the availability for use by the Company. The net deferred tax asset consisted of the following at December 31, 2013 and 2012:
	Deferred Tax Asset	2013		2012
	Operating loss carry forwards	$5,305,728		$   4,383,290
	Depreciation	-		-
	Total Deferred Tax Asset	5,305,728		4,383,290
	Valuation Allowance	(5,305,728)		(4,383,290)
	Net Deferred Tax Asset	$                 -		$                    -
	During 2013 and 2012, the valuation allowance increased by $922,438 and $530,172, respectively, principally due to the operating losses.
	The following is a reconciliation of the amount of tax benefit that would result from applying the federal statutory rate to pretax loss from continuing operations with the benefit from income taxes attributable to continuing operations:
			2013		2012
	Income tax (benefit) at statutory rate (34%)		$        922,438		$   (530,172)
	Benefit of operating loss carry-forwards		-		-
	Expenses not currently deductible		-		-
	Change in valuation allowance		(922,438)		530,172
	State tax (benefit), net of federal tax effect		-		-
	Net Benefit (Expenses) From Income Taxes		$                  -		$                      -

Note_12_Commitments_and_Contin

Note 12 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 12 - Commitments and Contingencies	'
	NOTE 12 – COMMITMENTS AND CONTINGENCIES
	Several of the Company’s note payables are past due.  No law suits have been filed concerning these past due notes and currently the Company has limited options as to how to repay these notes.

Note_13_Legal_Issues

Note 13 - Legal Issues	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 13 - Legal Issues	'
	NOTE 13 – LEGAL ISSUES
	On March 25, 2013 a Complaint was filed against Ensurge, by Randall K. Edwards and Gaia, Silva, Gaede & Associates in the amount of $74,924 and $18,627, respectively.  These are liabilities for services performed, however, due to lack of funding the Company has not been able to pay these amount owed.  These liabilities are booked as part of accounts payable.

Note_14_Acquisition_and_Decons

Note 14 - Acquisition and Deconsolidation	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 14 - Acquisition and Deconsolidation	'
	NOTE 14 – ACQUISITION AND DECONSOLIDATION
	On May 23, 2013, the Company issued 6,000,000 shares of common stock for 80% ownership of TransGlobal Gold Corporation, a Nevada Corporation and 200,000 shares to employees.  Due to not being able to obtain audited financial statements from TransGlobal, the Company deconsolidated this subsidiary.  The Company had invested $322,400 of cash and stock to keep operations going, however, the Company has created a 100% reserve for this investment.

Note_15_Gain_On_Sale_of_Subsid

Note 15 - Gain On Sale of Subsidiary	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 15 - Gain On Sale of Subsidiary	'
	NOTE 15 – GAIN ON SALE OF SUBSIDIARY
	On December 31, 2013, the Company entered into a contract to sell its Brazilian subsidiary, Ensurge Brasil LTDA.  The Company has two notes payable of $756,250 each and accrued interest of $163,854 as of December 31, 2013 which was moved to the Ensurge Brasil LTDA thereby releasing Ensurge of this liability. Due to this sell the Company has recognized a gain on sale of subsidiary of $1,676,354.

Note_16_Subsequent_Events

Note 16 - Subsequent Events	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 16 - Subsequent Events	'
	NOTE 16 – SUBSEQUENT EVENTS
	On January 17, 2014, Jamie D. Miller resigned as President and CEO, and Paul C. Cinquemani took his place as President, CEO, and member of the Board of Directors.  On March 27, 2014, Paul C. Cinquemani, resigned as President, CEO, and a member of the Board of Directors for the Company.  On March 27, 2014, Jeff A Hanks became the President, CEO and CFO for the Company.
	During the month of January 2014, the Company issued 450,000 shares of common stock in exchange for services for TransGlobal Gold Corp.
	On February 4, 2014, the Company entered into a nine month note payable of $32,500 with interest payable at 8% APR.
	During the month of February 2014, the Company issued 1,180,000 shares of common stock in exchange for services for TransGlobal Gold Corp.
	During the month of March 2014, the Company issued 100,000 shares of common stock in exchange for services for TransGlobal Gold Corp.
	On March 27, 2014, the Company entered into a nine month note payable of $6,500 with interest payable at 8% APR.
	During the month of April 2014, the Company issued 9,100,000 shares of common stock for services for Ensurge.
	Also, during the month of April 2014, the Company received back into treasury 3,348,780 shares of common stock of Ensurge for services which were not completed.
	The Company has reviewed subsequent events from the balance sheet date through the date the consolidated financial statements were available to be issued, and have determined there were no other events to disclose.

Note_1_Summary_of_Significant_1

Note 1 - Summary of Significant Accounting Policies: Use of Estimates (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Use of Estimates	'
	Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.

Note_1_Summary_of_Significant_2

Note 1 - Summary of Significant Accounting Policies: Basis of Presentation - Going Concern (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Basis of Presentation - Going Concern	'
	Basis of Presentation – Going Concern
	The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern. The Company is under exploration stage and has not commenced its planned operations. As shown in the accompanying consolidated financial statements, the Company has not generated any revenue and has incurred recurring losses for the period from January 1, 2010 (date of inception of exploration stage) through December 31, 2013. Additionally, the Company has negative cash flows from operating activities, has stockholders’ deficit and working capital deficit. Therefore it may be forced to discontinue operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	Management plans to raise additional capital to complete its business plan. However, there can be no assurance that these arrangements will be sufficient to fund its ongoing capital expenditures, working capital, and other cash requirements. The outcome of these matters cannot be predicted at this time.
	There can be no assurance that any additional financings will be available to the Company on satisfactory terms and conditions, if at all.
	The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

Note_1_Summary_of_Significant_3

Note 1 - Summary of Significant Accounting Policies: Business Condition (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Business Condition	'
	Business Condition – The Company has suffered losses from operations, has had negative cash flows from operating activities for all periods since inception. The Company has issued a private placement memorandum to obtain investors. During 2010, the Company sold an aggregate of 3,100,000 shares of common stock to investors for an aggregate purchase price of $894,900 in a private placement. The Company received $1,360,000 in exchange for warrants exercisable for the right to purchase 5,600,000 shares of the Company’s common stock in a private placement. In August 2011 the Company entered into a 90 day note payable in the amount of $500,000. During October 2011 the Company entered into a two 12 month notes payable for an aggregate of $1,100,000, which proceeds were used to pay off early the 90 day note and operating capital. During November 2012, the Company negotiated an extension of these two notes payable, which are due on March 15, 2013. The principal was increase from $550,000 per note to $756,250, or a total of $1,512,500. As part of this negotiation to extend the note, the Company agreed to pay a total of 900,000 shares of common stock.
	On March 2, 2012, the Company accepted $380,000 in private placement funds from accredited investors in exchange for units consisting of seven hundred sixty thousand (760,000) shares of the Company’s common stock, plus three hundred eighty thousand (380,000) warrants with an exercise price of $1.00.  During November 2012 the Company entered into several 12 month notes payable for an aggregate of $150,000. The proceeds of the financing will be used to help the Company maintain operations and to fund the exploration of acquisitions.

Note_1_Summary_of_Significant_4

Note 1 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Principles of Consolidation	'
	Principles of Consolidation – The financial statements have been consolidated with its wholly owned subsidiary, Ensurge Brazil, LTDA., which was incorporated in Sao Paulo, Brazil on April 18, 2011.  Currently the Brazil entity has no assets, liabilities, revenues or expenses.  During December 2013, the Company divested itself of the Brazil entity, including all assets and liabilities.

Note_1_Summary_of_Significant_5

Note 1 - Summary of Significant Accounting Policies: Stock-Based Compensation (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Stock-Based Compensation	'
	Stock-Based Compensation – Effective January 1, 2006, the Company adopted, “Share-Based Payment” (ASC Topic 718) requiring that compensation cost relating to share-based payment awards made to employees and directors be recognized in the consolidated financial statements. There were no options granted during the years ended December 31, 2013 and 2012.
	Prior to January 1, 2006, the Company accounted for its stock options issued to directors, officers and employees under ASC Topic 835 and related interpretations. Under ASC Topic 835, compensation expense is recognized if an option’s exercise price on the measurement date is below the fair value of the Company’s common stock. The Company also accounted for options and warrants issued to non-
	employees in accordance with ASC Topic 718 which required these options and warrants to be accounted for at their fair value.

Note_1_Summary_of_Significant_6

Note 1 - Summary of Significant Accounting Policies: Basic And Diluted Earnings Per Share (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Basic And Diluted Earnings Per Share	'
	Basic and Diluted Earnings Per Share – Basic loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is calculated to give effect to potentially issuable common shares which include stock options and stock warrants except during loss periods when those potentially issuable common shares would decrease loss per share. During 2013, the Company issued 33,190,000 common shares and 2,822,000 warrants as part of debt financing and services.  During 2012, the Company issued 1,690,000 common shares and 380,000 warrants as part of private placement funding, debt financing and services.

Note_1_Summary_of_Significant_7

Note 1 - Summary of Significant Accounting Policies: Income Taxes (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Income Taxes	'
	Income Taxes – The Company recognizes an asset or liability for the deferred tax consequences of all temporary differences between the tax bases of assets or liabilities and their reported amounts in the financial statements that will result in taxable or deductible amounts in future years when the reported amounts of the asset or liabilities are recovered or settled and for operating loss carry forwards. These deferred tax assets and liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to reverse and the carry forwards are expected to be realized. Deferred tax assets are reviewed periodically for recoverability and a valuation allowance is provided as necessary.

Note_1_Summary_of_Significant_8

Note 1 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Cash and Cash Equivalents	'
	Cash and Cash Equivalents - The Company considers all highly liquid instruments purchased with an original maturity of three months or less and money market accounts to be cash equivalents. There were no cash equivalents at December 31, 2013 and 2012.

Note_1_Summary_of_Significant_9

Note 1 - Summary of Significant Accounting Policies: Derivative Liabilities (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Derivative Liabilities	'
	Derivative Liabilities - The Company assessed the classification of its derivative financial instruments as of December 31, 2013, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.
	ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

Recovered_Sheet1

Note 1 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments - Effective January 1, 2008, the Company adopted FASB ASC 820-Fair Value Measurements and Disclosures, or ASC 820, for assets and liabilities measured at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position or operating results, but did expand certain disclosures.
	ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:
	Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities
	Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data
	Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions
	The Company did not have any Level 2 or Level 3 assets or liabilities as of December 31, 2013, with the exception of its convertible notes payable. The carrying amounts of these liabilities at December 31, 2013 approximate their respective fair value based on the Company’s incremental borrowing rate.
	Cash is considered to be highly liquid and easily tradable as of December 31, 2013 and therefore classified as Level 1 within our fair value hierarchy.
	In addition, FASB ASC 825-10-25 Fair Value Option, or ASC 825-10-25, was effective for January 1, 2008. ASC 825-10-25 expands opportunities to use fair value measurements in financial reporting and permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value options for any of its qualifying financial instruments.

Recovered_Sheet2

Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Property and Equipment	'
	Property and Equipment - Property and equipment are stated at cost. Depreciation is computed on the straight-line method. The depreciation and amortization methods are designed to amortize the cost of the assets over their estimated useful lives.
	Amortization of leasehold improvements is computed using the straight-line method over the shorter of the life of the lease or the estimated useful life of the assets. Maintenance and repairs are charged to expense as incurred. Improvements of a major nature are capitalized. At the time of retirement or other disposition of property and equipment, the cost and accumulated depreciation are removed from the accounts and any gains or losses are reflected in income.
	The Company reviews the carrying value of property and equipment for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of assets. The factors considered by management in performing this assessment include current operating results, trends and prospects, the manner in which the property is used, and the effects of obsolescence, demand, competition, and other economic factors. Based on this assessment there was no impairment at December 31, 2013 and 2012.

Recovered_Sheet3

Note 1 - Summary of Significant Accounting Policies: Recently Enacted Accounting Standards (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Recently Enacted Accounting Standards	'
	Recently Enacted Accounting Standards – The Company will adopt in future the Accounting Standards Update (ASU) No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this ASU remove all incremental financial reporting requirements from U.S. GAAP for development stage entities, including the removal of Topic 915, Development Stage Entities, from the FASB Accounting Standards Codification.
	A development stage entity is one that devotes substantially all of its efforts to establishing a new business and for which: (a) planned principal operations have not commenced; or (b) planned principal operations have commenced, but have produced no significant revenue. For example, many start-ups or even long-lived organizations that have not yet begun their principal operations or do not have significant revenue would be identified as development stage entities.
	For public business entities, the presentation and disclosure requirements in Topic 915 will no longer be required for the first annual period beginning after December 15, 2014. The revised consolidation standards are effective one year later, in annual periods beginning after December 15, 2015. Early adoption is permitted.
	We have reviewed accounting pronouncements issued during the past two years and have adopted any that are applicable to our company. We have determined that none had a material impact on our consolidated financial position, results of operations, or cash flows for the years ended December 31, 2013 and 2012.

Note_4_Plant_Property_and_Equi1

Note 4 - Plant, Property and Equipment: Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Property, Plant and Equipment	'
		2013	2012
	Equipment	$            -	$     55,073
	Computer hardware	-	3,817
	Accumulated depreciation		-9,439
		-
		$           -	$    49,451

Note_6_Common_Stock_Warrants_a1

Note 6 - Common Stock Warrants and Options: Schedule Of Common Stock Warrants And Options (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule Of Common Stock Warrants And Options	'
		Options		Warrants
		12/31/13	12/31/12	12/31/13	12/31/12
	Beginning Balance	7,500,000	7,500,000	8,330,000	7,950,000
	Granted/Issued	-	-	2,822,000	380,000
	Exercised	-	-	-	-
	Cancelled	-	-	-	-
	End Balance	7,500,000	7,500,000	11,152,000	8,330,000
	Exercisable	7,500,000	7,500,000	11,152,000	8,330,000

Note_6_Common_Stock_Warrants_a2

Note 6 - Common Stock Warrants and Options: Schedule Of Granted Outstanding Warrants (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule Of Granted Outstanding Warrants	'
	Date of issuance	Stock price at valuation date of May 30, 2013 and	Exercise price	Term	Risk free rate	Volatility	Value	# of Warrants
		December 31, 2013
	30-May-13	$           0.04	$   0.75	2 Year	0.36%	316%	$               -	420,000
	30-May-13	$           0.04	$   0.50	2 Year	0.36%	316%	$               -	420,000
	30-May-13	$           0.04	$   0.38	2 Year	0.36%	316%	$               -	420,000
	30-May-13	$           0.04	$   0.25	2 Year	0.36%	316%	$               -	142,000
	30-May-13	$           0.04	$   0.13	2 Year	0.36%	316%	$               -	1,420,000
	2-Mar-12	$           0.04	$   1.00	5 Year	0.36%	316%	$               -	380,000
	28-Oct-11	$           0.04	$  1.00	5 Year	0.36%	316%	$               -	1,900,000
	30-Dec-10	$           0.04	$   0.50	5 Year	0.36%	316%	$               -	1,600,000
	9-Dec-10	$           0.04	$   1.00	5 Year	0.36%	316%	$               -	450,000
	27-Jul-10	$           0.04	$   0.14	5 Year	0.36%	316%	$               -	4,000,000
	Total						$               -	11,152,000

Note_6_Common_Stock_Warrants_a3

Note 6 - Common Stock Warrants and Options: Schedule Of Warrants Adjusted For Changes In Exercise Price (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule Of Warrants Adjusted For Changes In Exercise Price	'
		Warrants Outstanding				Warrants Exercisable
		Range of exercise price	Number Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price	Number Exercisable	Weighted Average Exercise Price
		$0.13	11,152,000	2.96 years	$          0.50	11,152,000	$    0.50
		to $1.00
			Exercise Price		$0.13
					to $1.00
			Term		Two to
					Five years25
			Volatility		261%
			Dividends		0%

Note_6_Common_Stock_Warrants_a4

Note 6 - Common Stock Warrants and Options: Schedule of Share-based Compensation, Stock Options, Activity (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Share-based Compensation, Stock Options, Activity	'
		Options Outstanding				Options Exercisable
		Range of exercise price	Number Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price	Number Exercisable	Weighted Average Exercise Price
		$0.14 to $0.50	7,500,000	7.63 years	$            0.25	7,500,000	$        0.25

Note_9_Convertible_Notes_Payab1

Note 9 - Convertible Notes Payable: Schedule of Assumptions Used (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Assumptions Used	'
	Dividend yield:	-0-	%
	Volatility	483	%
	Risk free rate:	0.13	%

Note_10_Fair_Value_of_Financia1

Note 10 - Fair Value of Financial Instrument: Fair Value, Liabilities Measured on Recurring Basis (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Fair Value, Liabilities Measured on Recurring Basis	'
				Fair Value Measurements at December 31, 2013 using:
		December 31,		Quoted Prices			Significant		Significant
		2013		in Active			Other		Unobservable
				Markets for			Observable		Inputs
				Identical			Inputs (Level 2)		(Level 3)
				Assets
				(Level 1)
	Liabilities:
	Debt Derivative Liabilities	$	60,324		-			-	$	60,324
	Warrant Derivative Liabilities	$	314,305			-		-	$	314,305

Note_10_Fair_Value_of_Financia2

Note 10 - Fair Value of Financial Instrument: Schedule of Changes in Fair Value of Plan Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Changes in Fair Value of Plan Assets	'
		Debt Derivative			Warrant Derivative Liability
		Liability
	Balance, December 31, 2012	$	-	$	903,142
	Initial fair value of debt derivatives at note issuances on December 6, 2013		73,660		-
	Change in fair value of derivative liability		-13,336		-588,837
	Balance, December 31, 2013	$	60,324	$	314,305
	Net gain for the period included in earnings relating to the liabilities held at December 31, 2013	$	13,336		588,837
				$

Note_11_Provision_For_Income_T1

Note 11 - Provision For Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Deferred Tax Assets and Liabilities	'
	Deferred Tax Asset	2013	2012
	Operating loss carry forwards	$5,305,728	$   4,383,290
	Depreciation	-	-
	Total Deferred Tax Asset	5,305,728	4,383,290
	Valuation Allowance	(5,305,728)	(4,383,290)
	Net Deferred Tax Asset	$                 -	$                    -

Note_11_Provision_For_Income_T2

Note 11 - Provision For Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Components of Income Tax Expense (Benefit)	'
		2013	2012
	Income tax (benefit) at statutory rate (34%)	$        922,438	$   (530,172)
	Benefit of operating loss carry-forwards	-	-
	Expenses not currently deductible	-	-
	Change in valuation allowance	(922,438)	530,172
	State tax (benefit), net of federal tax effect	-	-
	Net Benefit (Expenses) From Income Taxes	$                  -	$                      -

Recovered_Sheet4

Note 1 - Summary of Significant Accounting Policies: Business Condition (Details) (USD $)	12 Months Ended		39 Months Ended	48 Months Ended
	Dec. 31, 2012	Dec. 31, 2010	Mar. 31, 2013	Dec. 31, 2013	Nov. 30, 2012	Mar. 02, 2012	Dec. 31, 2011	Aug. 31, 2011
Common stock shares issued	67,228,726	3,100,000	'	67,228,726	'	'	'	'
Proceeds from Issuance of Common Stock	$380,000	$894,900	'	$1,274,900	'	'	'	'
Proceeds from exercise of warrants for common stock to be issued	'	1,360,000	1,360,000	1,360,000	'	'	'	'
Common stock shares purchased with warrants exercised	'	5,600,000	'	'	'	'	'	'
August 2011 Short term note	'	'	'	'	'	'	'	500,000
Notes payable	1,662,500	'	'	209,050	'	'	1,100,000	'
12 Month Notes Payable Original Principle	'	'	'	'	550,000	'	'	'
12 Month Notes Payable Increased Principle	'	'	'	756,250	756,250	'	'	'
Shares Issued For 12 Month Notes Payable	'	'	'	'	900,000	'	'	'
Proceeds From Issuance Of Private Placement	'	'	'	'	'	380,000	'	'
Warrants issued in private placement	'	'	'	'	'	380,000	'	'
Exercise price on warrants	'	'	'	'	'	$1	'	'
12 Month Notes Payable	'	'	'	'	150,000	'	'	'
Common Stock	'	'	'	'	'	'	'	'
Stock sold for cash - Shares	760,000	3,100,000	'	'	'	'	'	'
November 2012 Note Payable - 1	'	'	'	'	'	'	'	'
Notes payable	$1,512,500	'	'	'	'	'	'	'

Recovered_Sheet5

Note 1 - Summary of Significant Accounting Policies: Basic And Diluted Earnings Per Share (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Common Stock Issued For Placement Funding	33,190,000	1,690,000
Warrants Issued For Placement Funding	2,822,000	380,000

Note_2_Investment_in_Mining_Ri1

Note 2 - Investment in Mining Rights (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Exploration Expense, Mining	$0	$106,592

Note_3_Proceeds_For_Common_Sto1

Note 3 - Proceeds For Common Stock To Be Issued (Details) (USD $)	1 Months Ended		12 Months Ended
	Nov. 30, 2012	Dec. 31, 2010	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Mar. 02, 2012
Stock issued for services	'	'	$120,800	$15,000	$745,800	$1,051,500	'
Common Stock Issued For Note Extention	900,000	'	'	'	'	'	'
Proceeds From Issuance Of Private Placement	'	'	'	'	'	'	380,000
Warrants issued in private placement	'	'	'	'	'	'	380,000
Common Stock Received From Cashless Exercise Of Warrants	'	'	'	'	2,945,250	'	'
Warrants Sold For Right To Purchase Common Stock	'	'	'	'	'	4,000,000	'
Warrant Sold Value	'	'	'	'	'	100	'
Common Stock Purchased From Sell Of Warrants	'	'	'	'	'	4,000,000	'
Common Stock Purchased From Sell Of Warrants Share Price	'	'	'	'	'	$0.14	'
Proceeds From Sell Of Warrants For Common Shares	'	'	'	'	'	560,100	'
Proceeds For Exercisable Warrants	'	800,000	'	'	'	'	'
Common Stock Issued From Proceeds For Exercisable Warrants	'	1,600,000	'	'	'	'	'
Common Stock	'	'	'	'	'	'	'
Stock issued for services - Shares	'	'	2,220,000	30,000	252,000	2,350,000	'
Stock issued for services	'	'	$2,220	$30	$252	$2,350	'
Stock sold for cash - Shares	'	'	'	760,000	'	3,100,000	'
Stock cancelled - shares	'	'	'	'	375,000	'	'

Note_4_Plant_Property_and_Equi2

Note 4 - Plant, Property and Equipment: Property, Plant and Equipment (Details) (USD $)	Dec. 31, 2012
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	($9,439)
Fixed assets (net of depreciation)	49,451
Equipment	'
Property, Plant and Equipment, Gross	55,073
Computer Equipment	'
Property, Plant and Equipment, Gross	$3,817

Note_4_Plant_Property_and_Equi3

Note 4 - Plant, Property and Equipment (Details) (USD $)	12 Months Ended		48 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Proceeds from sale of fixed assets	$1,550	'	$1,550
Loss on sale of fixed assets, net	-39,610	'	-39,610
Depreciation expense	8,291	8,485	17,730
Computer Equipment	'	'	'
Proceeds from sale of fixed assets	1,550	'	'
Book Value	1,167	'	'
Loss on sale of fixed assets, net	383	'	'
Equipment	'	'	'
Book Value	39,993	'	'
Loss on sale of fixed assets, net	$39,993	'	'

Note_5_Warrant_Derivative_Liab1

Note 5 - Warrant Derivative Liability (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Warrants derivative liability	$314,305	$903,142

Note_6_Common_Stock_Warrants_a5

Note 6 - Common Stock Warrants and Options (Details)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Details	'	'	'
Outstanding Warrants	11,152,000	8,330,000	7,950,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	7,500,000	7,500,000	'

Note_6_Common_Stock_Warrants_a6

Note 6 - Common Stock Warrants and Options: Schedule Of Common Stock Warrants And Options (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Details	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	7,500,000	7,500,000	'
Outstanding Warrants	11,152,000	8,330,000	7,950,000
Warrants Issued	2,822,000	380,000	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	7,500,000	7,500,000	'
Warrants Exercisable	11,152,000	8,330,000	'

Note_6_Common_Stock_Warrants_a7

Note 6 - Common Stock Warrants and Options: Schedule Of Granted Outstanding Warrants (Details) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

30-May-13

Dec. 31, 2013

30-May-13

Dec. 31, 2013

30-May-13

Dec. 31, 2013

30-May-13

Dec. 31, 2013

30-May-13

Dec. 31, 2013

Mar. 02, 2012

Dec. 31, 2013

Oct. 28, 2011

Dec. 31, 2012

Dec. 30, 2010

Dec. 31, 2012

Dec. 09, 2010

Dec. 31, 2012

Jul. 27, 2010

May 30, 2013 - 1

May 30, 2013 - 1

May 30, 2013 - 2

May 30, 2013 - 2

May 30, 2013 - 3

May 30, 2013 - 3

May 30, 2013 - 4

May 30, 2013 - 4

May 30, 2013 - 5

May 30, 2013 - 5

2-Mar-12

2-Mar-12

28-Oct-11

28-Oct-11

30-Dec-10

30-Dec-10

9-Dec-10

9-Dec-10

27-Jul-10

27-Jul-10

Stock Price

'

'

'

'

$0.04

'

$0.04

'

$0.04

'

$0.04

'

$0.04

'

$0.04

'

$0.04

'

$0.04

'

$0.04

'

$0.04

Fair Value Assumptions, Exercise Price

'

'

'

'

$0.75

'

$0.50

'

$0.38

'

$0.25

'

$0.13

'

$1

'

$1

'

$0.50

'

$1

'

$0.14

Fair Value Assumptions, Expected Term

'

'

'

'2 years

'

'2 years

'

'2 years

'

'2 years

'

'2 years

'

'5 years

'

'5 years

'

'5 years

'

'5 years

'

'5 years

'

Fair Value Assumptions, Risk Free Interest Rate

0.13%

'

'

0.36%

'

0.36%

'

0.36%

'

0.36%

'

0.36%

'

0.36%

'

0.36%

'

0.36%

'

0.36%

'

0.36%

'

Fair Value Assumptions, Expected Volatility Rate

483.00%

'

'

316.00%

'

316.00%

'

316.00%

'

316.00%

'

316.00%

'

316.00%

'

316.00%

'

316.00%

'

316.00%

'

316.00%

'

Outstanding Warrants

11,152,000

8,330,000

7,950,000

'

420,000

'

420,000

'

420,000

'

142,000

'

1,420,000

'

380,000

'

1,900,000

'

1,600,000

'

450,000

'

4,000,000

Note_6_Common_Stock_Warrants_a8

Note 6 - Common Stock Warrants and Options: Schedule Of Warrants Adjusted For Changes In Exercise Price (Details) (USD $)	12 Months Ended				12 Months Ended		12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 02, 2012	Dec. 31, 2011	Dec. 31, 2013	30-May-13	Dec. 31, 2013	30-May-13
					Minimum	Minimum	Maximum	Maximum
Exercise price on warrants	'	'	$1	'	$0.13	$0.13	$1	$0.75
Outstanding Warrants	11,152,000	8,330,000	'	7,950,000	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'	'	'	'	'	'	'2 years 11 months 16 days	'
WarrantsWeighted Average Exercise Price	$0.50	'	'	'	'	'	'	'
Warrants Exercisable	11,152,000	8,330,000	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'	'	'	'	2	'	5	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	261.00%	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Range of Dividends Used	'0%	'	'	'	'	'	'	'

Note_6_Common_Stock_Warrants_a9

Note 6 - Common Stock Warrants and Options: Schedule of Share-based Compensation, Stock Options, Activity (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	7,500,000	7,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	'7 years 7 months 17 days	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.25	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	7,500,000	7,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$0.25	'
Minimum	'	'
Fair Value Assumptions, Exercise Price	$0.14	'
Maximum	'	'
Fair Value Assumptions, Exercise Price	$0.50	'

Note_7_Issuance_of_Stock_Detai

Note 7 - Issuance of Stock (Details) (USD $)

1 Months Ended

12 Months Ended

48 Months Ended

Nov. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 30, 2010

Dec. 31, 2010

Dec. 31, 2013

Sep. 05, 2013

30-May-13

23-May-13

22-May-13

15-May-13

Mar. 02, 2012

Stock issued for services

'

$120,800

$15,000

$745,800

'

$1,051,500

'

'

'

'

'

'

'

Common Stock Issued For Note Extention

900,000

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds From Issuance Of Private Placement

'

'

'

'

'

'

'

'

'

'

'

'

380,000

Warrants issued in private placement

'

'

'

'

'

'

'

'

'

'

'

'

380,000

Notes payable

'

209,050

1,662,500

1,100,000

'

'

209,050

'

'

'

'

'

'

Common Stock Issued As Part Of Ensurge Brasil LTDA Notes Payable

'

'

'

'

'

'

'

'

'

'

'

1,000,000

'

Company Acquired a Percentage of Transglobal Gold Corporation

'

'

'

'

'

'

'

'

'

80.00%

'

'

'

Common Stock Issued To Employees For Acquisition of TransGlobal

'

200,000

'

'

'

'

'

'

'

'

'

'

'

Stock issued for acquisition of TransGlobal

'

660,000

'

'

'

'

'

'

'

'

'

'

'

Stock Issued To Employees For Acquisition of TransGlobal

'

22,000

'

'

'

'

'

'

'

'

'

'

'

Stock issued for accrued expenses

'

10,000

'

'

'

'

10,000

'

'

'

'

'

'

Common Stock Issued For Cash And A Note Payable

'

'

'

'

'

'

'

'

'

'

1,000,000

'

'

Stock subscription receivable

'

75,000

'

'

'

'

75,000

'

'

'

'

'

'

Common Stock Issued in Employment Agreement with the Company's President

'

'

'

'

'

'

'

'

1,420,000

'

'

'

'

Warrants Issued in Employment Agreement with the Company's President

'

'

'

'

'

'

'

'

2,822,000

'

'

'

'

Exercise price on warrants

'

'

'

'

'

'

'

'

'

'

'

'

$1

Stock issued for investment in TransGlobal

'

302,800

'

'

'

'

302,800

'

'

'

'

'

'

Common Stock Issued for Services for Ensurge

'

'

'

'

'

'

'

600,000

'

'

'

'

'

Common Stock sold to an investor in February and March

'

'

'

'

2,100,000

'

'

'

'

'

'

'

'

Proceeds from Common Stock sold to an investor in February and March

'

'

'

'

525,000

'

'

'

'

'

'

'

'

Proceeds received in exchange for warrants exercisable in July

'

'

'

'

560,000

'

'

'

'

'

'

'

'

Warrants exercisable issued in July

'

'

'

'

4,000,000

'

'

'

'

'

'

'

'

Common Stock sold to an investor in December

'

'

'

'

1,000,000

'

'

'

'

'

'

'

'

Warrants exercisable sold to an investor in December

'

'

'

'

500,000

'

'

'

'

'

'

'

'

Proceeds from Common Stock sold to an investor in December

'

'

'

'

500,000

'

'

'

'

'

'

'

'

Proceeds received in exchange for warrants exercisable in December

'

'

'

'

800,000

'

'

'

'

'

'

'

'

Warrants exercisable issued in December

'

'

'

'

1,600,000

'

'

'

'

'

'

'

'

Investment in TransGlobal Gold Corp 1

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal

'

30,000

'

'

'

'

'

'

'

'

'

'

'

Investment in TransGlobal Gold Corp 2

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal

'

210,000

'

'

'

'

'

'

'

'

'

'

'

Investment in TransGlobal Gold Corp 3

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal

'

40,000

'

'

'

'

'

'

'

'

'

'

'

Investment in TransGlobal Gold Corp 4

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal

'

22,800

'

'

'

'

'

'

'

'

'

'

'

Minimum

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise price on warrants

'

$0.13

'

'

'

'

$0.13

'

0.125

'

'

'

'

Maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise price on warrants

'

$1

'

'

'

'

$1

'

0.75

'

'

'

'

Workhorse Capital Leasing LLC

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock subscription receivable

'

50,000

'

'

'

'

'

'

'

'

'

'

'

OG3 LLC

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock subscription receivable

'

25,000

'

'

'

'

'

'

'

'

'

'

'

November 2012 Note Payable - 1

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes payable

'

'

1,512,500

'

'

'

'

'

'

'

'

'

'

Common Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for services - Shares

'

2,220,000

30,000

252,000

'

2,350,000

'

'

'

'

'

'

'

Stock issued for services

'

2,220

30

252

'

2,350

'

'

'

'

'

'

'

Stock sold for cash - Shares

'

'

760,000

'

'

3,100,000

'

'

'

'

'

'

'

Stock issued for acquisition of TransGlobal - Shares

'

6,000,000

'

'

'

'

'

'

'

'

'

'

'

Stock issued for acquisition of TransGlobal

'

6,000

'

'

'

'

'

'

'

'

'

'

'

Stock issued for accrued expenses - Shares

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

Stock issued for accrued expenses

'

2,000

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal - Shares

'

4,970,000

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal

'

4,970

'

'

'

'

'

'

'

'

'

'

'

Common Stock | Investment in TransGlobal Gold Corp 1

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal - Shares

'

500,000

'

'

'

'

'

'

'

'

'

'

'

Common Stock | Investment in TransGlobal Gold Corp 2

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal - Shares

'

3,500,000

'

'

'

'

'

'

'

'

'

'

'

Common Stock | Investment in TransGlobal Gold Corp 3

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal - Shares

'

400,000

'

'

'

'

'

'

'

'

'

'

'

Common Stock | Investment in TransGlobal Gold Corp 4

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for investment in TransGlobal - Shares

'

570,000

'

'

'

'

'

'

'

'

'

'

'

Common Stock | Workhorse Capital Leasing LLC

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Share Subscribed but Unissued, Subscriptions Receivable

'

10,000,000

'

'

'

'

10,000,000

'

'

'

'

'

'

Common Stock | OG3 LLC

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Share Subscribed but Unissued, Subscriptions Receivable

'

$5,000,000

'

'

'

'

$5,000,000

'

'

'

'

'

'

Note_8_Notes_Payable_Details

Note 8 - Notes Payable (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Nov. 30, 2012	Dec. 31, 2011	Oct. 31, 2011	Aug. 31, 2011
Convertible note payable net of debt discount of $38,678	$3,822	'	'	'	'	'
Warrants Issued For Notes Payable	'	'	'	'	'	561,000
Warrant Issued For Notes Payable Exercise Price	'	'	'	'	'	$1
Warrant Issued For Notes Payable Closing Price	'	'	'	'	'	$3
Warrant Issued For Notes Payable Interest Expense	'	'	'	'	'	1,122,000
Warrant Issued For Notes Payable Effective Interest Rate	'	'	'	'	'	3310.00%
Shares Issued by Warrant Cashless Exercise For Notes Payable	'	'	'	2,945,250	'	'
12 Month Convertible Notes Payable	'	'	'	'	1,210,000	'
issue discount	'	'	'	'	10.00%	'
Notes payable	209,050	1,662,500	'	1,100,000	'	'
12 Month Notes Payable Conversion Fixed Price	'	'	'	'	$1.50	'
Warrants Issued With 12 Month Notes Payable	'	'	'	'	950,000	'
Total Warrants Issued With 12 Month Notes Payable	'	'	'	'	1,900,000	'
Warrants Issued With 12 Month Notes Payable Exercise Price	'	'	'	'	$1	'
Warrants Issued With 12 Month Notes Payable Default Conversion Rate	'	'	'	'	$1.50	'
Warrants Issued With 12 Month Notes Payable Default Percent of Market Bid Price	'	'	'	'	$0.80	'
Funds Used To Pay Back 90 Day Convertible Notes Payable	'	'	'	'	561,000	'
12 Month Notes Payable Original Principle	'	'	550,000	'	'	'
12 Month Notes Payable Increased Principle	756,250	'	756,250	'	'	'
Bristol Investments	'	'	'	'	'	'
Convertible note payable net of debt discount of $38,678	'	'	'	'	'	280,500
Warrants Issued For Notes Payable	'	'	'	'	'	280,500
St. George Investments	'	'	'	'	'	'
Convertible note payable net of debt discount of $38,678	'	'	'	'	'	280,500
Warrants Issued For Notes Payable	'	'	'	'	'	280,500
November 2012 Note Payable - 1	'	'	'	'	'	'
Notes payable	'	1,512,500	'	'	'	'
November 2012 Note Payable - 2	'	'	'	'	'	'
Notes payable	'	150,000	'	'	'	'
April 2013 Note Payable	'	'	'	'	'	'
Notes payable	15,000	'	'	'	'	'
May 9, 2013 Note Payable	'	'	'	'	'	'
Notes payable	23,000	'	'	'	'	'
August 16, 2013 Note Payable	'	'	'	'	'	'
Notes payable	9,000	'	'	'	'	'
August 30, 2013 Note Payable	'	'	'	'	'	'
Notes payable	5,000	'	'	'	'	'
Oct Nov 2013 Note Payable	'	'	'	'	'	'
Notes payable	$7,050	'	'	'	'	'

Note_9_Convertible_Notes_Payab2

Note 9 - Convertible Notes Payable (Details) (USD $)	Dec. 31, 2013
Details	'
Convertible Notes Payable Gross	$42,500
Debt derivative liability	$60,324

Note_9_Convertible_Notes_Payab3

Note 9 - Convertible Notes Payable: Schedule of Assumptions Used (Details)	12 Months Ended
	Dec. 31, 2013
Details	'
Fair Value Assumptions, Expected Volatility Rate	483.00%
Fair Value Assumptions, Risk Free Interest Rate	0.13%

Note_10_Fair_Value_of_Financia3

Note 10 - Fair Value of Financial Instrument: Fair Value, Liabilities Measured on Recurring Basis (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Debt derivative liability	$60,324	'
Warrants derivative liability	314,305	903,142
Fair Value, Inputs, Level 3	'	'
Debt derivative liability	60,324	'
Warrants derivative liability	$314,305	'

Note_10_Fair_Value_of_Financia4

Note 10 - Fair Value of Financial Instrument: Schedule of Changes in Fair Value of Plan Assets (Details) (USD $)	12 Months Ended		48 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Debt derivative liability	$60,324	'	$60,324
Warrants derivative liability	314,305	903,142	314,305
Derivative gain	602,173	10,433,971	7,761,711
Debt Derivative Liability	'	'	'
Initial Fair Value of Debt Derivatives at Note Issuances	73,660	'	73,660
Derivative gain	-13,336	'	'
Warrant Derivative Liability	'	'	'
Derivative gain	($588,837)	'	'

Note_11_Provision_For_Income_T3

Note 11 - Provision For Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Operating Loss Carryforwards	$15,605,084	'
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$922,438	$530,172

Note_11_Provision_For_Income_T4

Note 11 - Provision For Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Deferred Tax Assets, Operating Loss Carryforwards	$5,305,728	$4,383,290
Deferred Tax Assets, Gross	5,305,728	4,383,290
Deferred Tax Assets, Valuation Allowance	($5,305,728)	($4,383,290)

Note_11_Provision_For_Income_T5

Note 11 - Provision For Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate	$922,438	($530,172)
Income Tax Reconciliation, Change in Deferred Tax Assets Valuation Allowance	($922,438)	$530,172

Note_13_Legal_Issues_Details

Note 13 - Legal Issues (Details) (USD $)	Mar. 25, 2013
Details	'
Complaint Filed Against Ensurge by Randall K Edwards	$74,924
Complaint Filed Against Ensurge by Gaia, Silva, Gaede and Associates	$18,627

Note_14_Acquisition_and_Decons1

Note 14 - Acquisition and Deconsolidation (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Common Stock Issued To Employees For Acquisition of TransGlobal	200,000
Reserves on Investment	$322,400
Common Stock	'
Stock issued for acquisition of TransGlobal - Shares	6,000,000

Note_15_Gain_On_Sale_of_Subsid1

Note 15 - Gain On Sale of Subsidiary (Details) (USD $)	12 Months Ended	48 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Nov. 30, 2012
Details	'	'	'
12 Month Notes Payable Increased Principle	$756,250	$756,250	$756,250
Accrued Interest moved to Ensurge Brasil LTDA	163,854	163,854	'
Gain on sale of subsidiary	$1,676,354	$1,676,354	'

Note_16_Subsequent_Events_Deta

Note 16 - Subsequent Events (Details) (USD $)	1 Months Ended
	Apr. 30, 2014	Mar. 31, 2014	Mar. 27, 2014	Feb. 28, 2014	Feb. 04, 2014	Jan. 31, 2014
Details	'	'	'	'	'	'
Balance - Shares	9,100,000	100,000	'	1,180,000	'	450,000
9 Month Note Payable	'	'	$6,500	'	$32,500	'
Purchase and cancel treasury stock - Shares	3,348,780	'	'	'	'	'